Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,225
datasets available to search
ShareScore release 0.9.0
Dataset results
5,225 results for “moderation”
Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease
ClinicalTrials.gov study NCT04994483. IPD Sharing: NO. Countries: 3. Publications: 1.
A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis Naive to Systemic Treatment
ClinicalTrials.gov study NCT02634801. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis
ClinicalTrials.gov study NCT05767021. IPD Sharing: YES. Countries: 10. Publications: 0.
Efficacy of Topical Azelaic Acid 15% Gel Plus Anti-inflammatory Dose Doxycycline or Metronidazole Gel 1% Plus Anti-inflammatory Dose Doxycycline in Moderate Papulopustular Rosacea
ClinicalTrials.gov study NCT00855595. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT03412747. IPD Sharing: YES. Countries: 9. Publications: 9.
A Study of Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's Disease
ClinicalTrials.gov study NCT00679627. IPD Sharing: Not stated. Countries: 12. Publications: 3.
Evaluation of the Efficacy and Tolerance of a Light Therapy Mask on Mild to Moderate Brown Spots and Moderate to Severe Facial Wrinkles
ClinicalTrials.gov study NCT03312543. IPD Sharing: NO. Countries: 1. Publications: 5.
A Study in Moderate to Severe Rheumatoid Arthritis Participants
ClinicalTrials.gov study NCT01721057. IPD Sharing: YES. Countries: 23. Publications: 13.
Evaluate the Maintenance of Efficacy of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder
ClinicalTrials.gov study NCT02009163. IPD Sharing: Not stated. Countries: 5. Publications: 2.
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF
ClinicalTrials.gov study NCT02163759. IPD Sharing: Not stated. Countries: 14. Publications: 2.
A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT01309737. IPD Sharing: Not stated. Countries: 11. Publications: 4.
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
ClinicalTrials.gov study NCT01257230. IPD Sharing: Not stated. Countries: 12. Publications: 4.
Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients
ClinicalTrials.gov study NCT01042392. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A 4 Week Study to Investigate the Safety and Tolerability of AZD5069 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
ClinicalTrials.gov study NCT01233232. IPD Sharing: Not stated. Countries: 4. Publications: 1.
CR845-CLIN3105: A Study to Evaluate the Safety and Effectiveness of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
ClinicalTrials.gov study NCT03998163. IPD Sharing: NO. Countries: 4. Publications: 5.
A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic Dermatitis
ClinicalTrials.gov study NCT04760314. IPD Sharing: YES. Countries: 1. Publications: 1.
Efficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 Year
ClinicalTrials.gov study NCT01365455. IPD Sharing: Not stated. Countries: 12. Publications: 9.
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
ClinicalTrials.gov study NCT03440385. IPD Sharing: Not stated. Countries: 31. Publications: 1.
Second-line Therapies for Patients With Type 2 Diabetes and Moderate Cardiovascular Disease Risk
ClinicalTrials.gov study NCT05214573. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1)
ClinicalTrials.gov study NCT04146363. IPD Sharing: YES. Countries: 10. Publications: 11.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.